Stockreport

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer

Fulgent Genetics, Inc.  (FLGT) 
Last fulgent genetics, inc. earnings: 3/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fulgentgenetics.com
PDF EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT) and a leading nanobiotechnology company specializing in inno [Read more]